Donor socioeconomic status as a predictor of altered immune function and treatment response following hematopoietic cell transplantation for hematologic malignancy.
Study #: IB20-03
Study Status: Published
Presentation(s)
2021, ASH (Oral)
2022, Tandem (Oral)
2023, ASCO (Oral)
2024, ASPO (Oral)